Yelda Yildiz Tasci

Yelda Yildiz Tasci

Auto-generated profile, based on publicly available information

Yelda Yildiz Tasci

Yildirim Beyazit University Faculty of Medicine

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
YTYelda Yıldız Taşçı
Yelda Yıldız Taşçı
GTGüzin Taşlıpınar
Güzin Taşlıpınar
DEDemet Eyidoğan
Demet Eyidoğan
ÖSÖzge Saraç
Özge Saraç
NÇNurullah Çağıl
Nurullah Çağıl
We aimed to demonstrate the 5-year visual, topographic, and aberrometry long-term results of standard collagen cross-linking (CCL) treatment in keratoconus patients. The files and topographic measurements of patients who underwent standard CCL treatment for progressive keratoconus were retrospectively reviewed. Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), refraction values, and topographic values were evaluated. Thirty-seven eyes of 27 patients were included in the study. The female to male ratio was 15 (56%)/12 (44%) and the mean age was 22.16±6.4 (12-39) years. The increase in UCVA and BCVA was statistically significant at postoperative 1-5 years (all p values 0.05), but the decrease in the manifest astigmatism values were significant after CCL at 3-5 years (p<0.05). Decrease in K2 (steep keratometry) and K apex values were statistically significant at 1-5 years (p<0.05). There was a significant decrease in the thinnest corneal thickness compared to the preoperative values up to 6 months and 1-4 years (p<0.05), but the change at 5 years was not significant (p=0.08). Post-CCL reductions in high-order aberrations and spherical aberrations were significant at postoperative 5 years and 3-5 years (p<0.05). In long-term follow-up, CCL treatment is seen to arrest keratoconus progression, increase vision, and improve visual quality by reducing higher-order aberrations and spherical aberrations. For these reasons, CCL treatment continues to be the first treatment modality in patients with progressive keratoconus.

7 May 2025 in BMC Ophthalmology
Verified
Journal Article
Open access
PDF file
SÇSebile Çomçalı
Sebile Çomçalı
YTYelda Yildiz Tasci
Yelda Yildiz Tasci
Mehmet ÖnenMehmet Önen
Mehmet Önen
BGBusra Gulhan
Busra Gulhan
MSMuzaffer Sahin
Muzaffer Sahin
ZYZeliha Yazar
Zeliha Yazar
To investigate the incidence, contributing factors, management, and long-term outcomes of endophthalmitis following intravitreal injections performed in our clinic. This retrospective study included all patients who received intravitreal bevacizumab, aflibercept, ranibizumab, or dexamethasone injections between 2019 and 2024 at four retina clinics of Ankara Bilkent City Hospital. Demographic characteristics of the patients, visual acuity, intravitreal injection etiology, comorbidities, and treatments applied were recorded. Patients who received antibiotic prophylaxis after intravitreal injections (IVI) were categorized as Group 1, while those who did not receive prophylaxis were classified as Group 2. A total of 4171 patients and 21,339 intravitreal injections were evaluated. Of the participants, 47.2% were female and 52.8% were male, with a mean age of 66.3 ± 10.3 years (range: 40–98). Group 1 included 13,121 injections (61%), while Group 2 had 8,218 injections (39%). Endophthalmitis was observed in 13 patients (3.0 per 1000 patients—8.1 per 10,000 injections). Patients who developed endophthalmitis had an average of 6.1 ± 4.1 prior injections (range: 2–16), and the mean time to presentation after the last injection was 7.6 ± 3.4 days (range: 2–14). Endophthalmitis cases were distributed as 7 in Group 1 (5.3 per 10,000) and 6 in Group 2 (4.4 per 10,000). The endophthalmitis rate in Group 1 was not statistically significantly different from Group 2 (p > 0.05). All patients received vitreous taps and intravitreal vancomycin-ceftazidime injections at initial presentation. Eleven patients (85%) underwent a pars plana vitrectomy within 24 h. The mean follow-up period was 32 ± 20 months, and any case did not require evisceration surgery. Early surgical intervention in cases of endophthalmitis is the most critical approach for preserving the eye and achieving visual rehabilitation. Notably, endophthalmitis was more common in people who got intravitreal bevacizumab or dexamethasone injections, and antibiotic prophylaxis did not appear to reduce the risk of its occurrence.

1 April 2024 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
HBHasan Ali Bayhan
Hasan Ali Bayhan
YTYelda Yıldız Taşcı
Yelda Yıldız Taşcı
SBSeray Aslan Bayhan
Seray Aslan Bayhan
TTTamer Takmaz
Tamer Takmaz
ICİzZet Can
İzZet Can
To evaluate the clinical results of a new trifocal intraocular lens (IOL) with sinusoidal design by comparing with a traditional trifocal IOL. A total of 79 patients undergoing uneventful microincisional cataract surgery with bilateral implantation of one of two types of trifocal IOLs, the Acriva Trinova IOL (VSY) or Acrysof IQ PanOptix IOL (Alcon), were enrolled in this prospective study. Visual and refractive outcomes, contrast sensitivity (CS), and defocus curve were assessed at 3 months after surgery. Patient satisfaction and incidence of photic phenomena were also evaluated. The number of patients/eyes were 48/96 in the Trinova group and 31/62 in the PanOptix group. There were no significant differences between the groups for monocular and binocular corrected/uncorrected distance or intermediate (at 60 cm) and near visual acuities (VA) postoperatively. The Trinova group had statistically significantly better intermediate VA at 80 cm than the PanOptix group (p<0.05). The CS results of both groups were within the normal limits. In the binocular defocus curve of both IOLs, we observed a peak of good VA at 0.0 diopters defocus and a useful wide range for intermediate distances. The incidence of photic phenomena in the Trinova group was lower at postoperative 1 month (p<0.05) but this difference disappeared at 3 months. A total of 47 patients (97.9%) in the Trinova group and 30 patients (96.7%) in the PanOptix group stated that they would recommend the same IOL. Both trifocal IOLs provide good visual quality outcomes and patient satisfaction.

28 April 2022 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
YTYelda Yıldız Tascı
Yelda Yıldız Tascı
PNPınar Nalcacoglu
Pınar Nalcacoglu
SGSadiye Gumusyayla
Sadiye Gumusyayla
GVGonul Vural
Gonul Vural
YTYasin Toklu
Yasin Toklu
NYNilüfer Yesılırmak
Nilüfer Yesılırmak
Neuromyelitis optica (NMO), also known as Devic’s disease, is a rare, autoimmune, and recurrent demyelinating disorder that primarily affects the spinal cord and optic nerve. We report a case with recurrent optic neuritis caused by the paraneoplastic NMO spectrum disorder in the setting of a gastric neuroendocrine tumor 2 weeks after receiving an inactive COVID-19 vaccine.

1 June 2023 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
YTYelda Yıldız Taşcı
Yelda Yıldız Taşcı
ÖSÖzge Saraç
Özge Saraç
NÇNurullah Çağıl
Nurullah Çağıl
Nilufer YesilirmakNilufer Yesilirmak
Nilufer Yesilirmak
Objectives: We aimed to compare the clinical results and topographic data of the new generation hybrid contact lens (HCL) and rigid gas - permeable contact lens (RGPCL) in patients with moderate and advanced keratoconus. Materials and Methods: In this prospective study, HCL users comprised group 1 and RGPCL users comprised group 2. Snellen uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), and lens-corrected visual acuity (LCVA); manifest spherical-cylindrical values; corneal topography measurements (flat keratometry [K1], vertical keratometry [K2], mean K, maximum K [Kmax], central corneal thickness [CCT], and thinnest corneal thickness [TCT]); and cone location were recorded. Results: The study included 83 eyes of 51 patients in group 1 and 61 eyes of 40 patients in group 2. The groups were similar in age and gender (p>0.05). Mean LCVA (logMAR) was significantly lower than BCVA in both groups (p0.05). There was also no significant difference between the two groups in terms of keratoconus stages, mean Kmax, CCT, TCT, or cone location (p>0.05), while mean UCVA (logMAR) and mean K were higher in group 2 (p<0.05). In both groups, the visual gain with lenses was higher in eyes with central cones, and there was significantly greater visual increase in group 2 (p=0.039).Conclusion: In moderate and advanced keratoconus, HCLs improved vision as much as RGPCLs and both lenses were more effective for central cones. Nevertheless, longer term of follow-up and larger numbers of patients are needed for long term follow-up results of HCL.

9 October 2024 in Cutaneous and Ocular Toxicology
Verified
Journal Article
Closed access
YTYelda Yildiz Tasci
Yelda Yildiz Tasci
MIMehmet Icoz
Mehmet Icoz
SISule Gokcek Gurturk Icoz
Sule Gokcek Gurturk Icoz
OSOzge Saritas
Ozge Saritas
MYMucella Arikan Yorgun
Mucella Arikan Yorgun
YTYasin Toklu
Yasin Toklu
To determine the effects of the first-dose administration of the Sinovac vaccine on the retina, choroid, and optic disc in healthy participants. This prospective design study was conducted with 27 healthy healthcare workers who received the first dose of Sinovac vaccine and 25 healthy controls who were not vaccinated. In the vaccinated group, ophthalmological examinations and measurements were performed before vaccination and one week and one month after vaccination. Subfoveal, nasal, and temporal choroidal thicknesses (CTs), retinal nerve fiber layer (RNFL) thickness, and macular thickness (MT) were determined using spectral domain-optical coherence tomography at all visits. Superficial, deep, and peripapillary radial capillary plexus (superficial capillary plexus, deep capillary plexus (DCP), and radial peripapillary capillary, respectively), choriocapillaris vascular density, and foveal avascular zone parameters were measured on optical coherence tomography-angiography (OCT-A). No significant difference was detected between the two groups in terms of the parameters measured by OCT and OCT-A (p > 0.05 for all). The CT values measured in all quadrants were significantly higher at the first week after vaccination (p < 0.05 for all), and they returned to their pre-vaccination values at the first month post-vaccination measurement (p > 0.05 for all). Concerning the RNFL and MT values, there was no significant difference between the pre-vaccination and post-vaccination first-week measurements (p > 0.05 for all), but a statistically significant increase was detected in the post-vaccination first-month MT and RNFL measurements (p < 0.05 for all). Only the decreases in the foveal DCP and choriocapillaris vascular density values were significant at the first week after vaccination (p < 0.05 for all). The early changes detected after vaccination in this study suggest the possibility that autoimmune, vascular, and inflammatory diseases may simultaneously emerge in the early post-vaccination period or may be triggered after vaccination, or that the vaccine may unmask these diseases.